{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:29:57Z","timestamp":1793644197293,"version":"4.5.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord Ser Cases"],"DOI":"10.1038\/s41394-020-00321-1","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T20:20:43Z","timestamp":1597350043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neuropathic pain in spinal cord injury: topical analgesics as a possible treatment"],"prefix":"10.1038","volume":"6","author":[{"given":"T. C.","family":"Crul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6793-691X","authenticated-orcid":false,"given":"J. M.","family":"Stolwijk-Sw\u00fcste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Kopsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M. A.","family":"Visser-Meily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2205-9404","authenticated-orcid":false,"given":"M. W. M.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"321_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejp.522","volume":"19","author":"S Van Gorp","year":"2015","unstructured":"Van Gorp S, Kessels AG, Joosten EA, Van Kleef M, Patijn J. Pain prevalence and its determinants after spinal cord injury: a systematic review. Eur J Pain. 2015;19:5\u201314.","journal-title":"Eur J Pain"},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/sc.2017.70","volume":"55","author":"NB Finnerup","year":"2017","unstructured":"Finnerup NB. Neuropathic pain and spasticity: intricate consequences of spinal cord injury. Spinal Cord. 2017;55:1046\u201350.","journal-title":"Spinal Cord"},{"key":"321_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.apmr.2016.11.011","volume":"98","author":"J Sauri","year":"2017","unstructured":"Sauri J, Chamarro A, Gilabert A, Gifre M, Rodriguez N, Lopez-Blazquez R, et al. Depression in individuals with traumatic and nontraumatic spinal cord injury living in the community. Arch Phys Med Rehabil. 2017;98:1165\u201373.","journal-title":"Arch Phys Med Rehabil"},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/ejp.1248","volume":"22","author":"D Burke","year":"2018","unstructured":"Burke D, Lennon O, Fullen BM. Quality of life after spinal cord injury: the impact of pain. Eur J Pain. 2018;22:1662\u201372.","journal-title":"Eur J Pain"},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0304-3959(02)00452-9","volume":"103","author":"PJ Siddall","year":"2003","unstructured":"Siddall PJ, McClelland JM, Rutkowski SB, Cousins MJ. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain. 2003;103:249\u201357.","journal-title":"Pain"},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0003-9993(99)90203-4","volume":"80","author":"EG Widerstrom-Noga","year":"1999","unstructured":"Widerstrom-Noga EG, Felipe-Cuervo E, Broton JG, Duncan RC, Yezierski RP. Perceived difficulty in dealing with consequences of spinal cord injury. Arch Phys Med Rehabil. 1999;80:580\u20136.","journal-title":"Arch Phys Med Rehabil"},{"key":"321_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/sc.2015.199","volume":"54","author":"JJ Van Middendorp","year":"2016","unstructured":"Van Middendorp JJ, Allison HC, Ahuja S, Bracher D, Dyson C, Fairbank J, et al. Top ten research priorities for spinal cord injury: the methodology and results of a British priority setting partnership. Spinal Cord. 2016;54:341\u20136.","journal-title":"Spinal Cord"},{"key":"321_CR8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.apmr.2010.01.022","volume":"91","author":"RW Teasell","year":"2010","unstructured":"Teasell RW, Mehta S, Aubut J-AL, Foulon B, Wolfe DL, Hsieh JTC, et al. A systematic review of pharmacologic treatments of pain after spinal cord injury. Arch Phys Med Rehabil. 2010;91:816\u201331.","journal-title":"Arch Phys Med Rehabil"},{"key":"321_CR9","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.apmr.2015.12.023","volume":"97","author":"S Mehta","year":"2016","unstructured":"Mehta S, McIntyre A, Janzen S, Loh E, Teasell R. Systematic review of pharmacologic treatments of pain after spinal cord injury: an update. Arch Phys Med Rehabil. 2016;97:1381\u2013.e1.","journal-title":"Arch Phys Med Rehabil"},{"key":"321_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2017.11.018","volume":"384","author":"MN Hatch","year":"2018","unstructured":"Hatch MN, Cushing TR, Carlson GD, Chang EY. Neuropathic pain and SCI: identification and treatment strategies in the 21st century. J Neurol Sci. 2018;384:75\u201383.","journal-title":"J Neurol Sci"},{"key":"321_CR11","first-page":"CD009177.","volume":"11","author":"I Boldt","year":"2014","unstructured":"Boldt I, Eriks-Hoogland I, Brinkhof MWG, de Bie R, Joggi D, von Elm E. Non-pharmacological interventions for chronic pain in people with spinal cord injury. Cochrane database Syst Rev. 2014;11:CD009177.","journal-title":"Cochrane database Syst Rev"},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1038\/sc.2016.90","volume":"54","author":"SD Guy","year":"2016","unstructured":"Guy SD, Mehta S, Casalino A, C\u00f4t\u00e9 I, Kras-Dupuis A, Moulin DE, et al. The CanPain SCI Clinical Practice Guidelines for rehabilitation management of neuropathic pain after spinal cord: recommendations for treatment. Spinal Cord. 2016;54:S14\u201323.","journal-title":"Spinal Cord"},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/ph11040122","volume":"11","author":"DJ Kopsky","year":"2018","unstructured":"Kopsky DJ, Keppel Hesselink JM. Single-blind placebo-controlled response test with phenytoin 10% cream in neuropathic pain patients. Pharmaceuticals. 2018;11:122.","journal-title":"Pharmaceuticals"},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/sc.2008.136","volume":"47","author":"PJ Siddall","year":"2009","unstructured":"Siddall PJ. Management of neuropathic pain following spinal cord injury: now and in the future. Spinal Cord. 2009;47:352\u20139.","journal-title":"Spinal Cord"},{"key":"321_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2009.09.030","volume":"147","author":"SM Carlton","year":"2009","unstructured":"Carlton SM, Du J, Tan HY, Nesic O, Hargett GL, Bopp AC, et al. Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury. Pain 2009;147:265\u201376.","journal-title":"Pain"},{"key":"321_CR16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1526-4637.2012.01362.x","volume":"13","author":"DJ Kopsky","year":"2012","unstructured":"Kopsky DJ, Amelink GJ, Keppel Hesselink JM. Intractable neuropathic pain in spinal intramedullary cavernoma treated successfully with a novel combination cream. Pain Med. 2012;13:729\u201330.","journal-title":"Pain Med"},{"key":"321_CR17","doi-asserted-by":"publisher","first-page":"764950.","DOI":"10.1155\/2015\/764950","volume":"2015","author":"DJ Kopsky","year":"2015","unstructured":"Kopsky DJ, Keppel Hesselink JM, Casale R. Walking with neuropathic pain: paradoxical shift from burden to support? Case Rep Med. 2015;2015:764950.","journal-title":"Case Rep Med"},{"key":"321_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.sc.3102098","volume":"46","author":"GH Hans","year":"2008","unstructured":"Hans GH, Robert DN, Van Maldeghem KN. Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: A case report. Spinal Cord. 2008;46:311\u20133.","journal-title":"Spinal Cord"},{"key":"321_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.pain.2007.03.005","volume":"131","author":"G Wasner","year":"2007","unstructured":"Wasner G, Naleschinski D, Baron R. A role for peripheral afferents in the pathophysiology and treatment of at-level neuropathic pain in spinal cord injury? A case report. Pain. 2007;131:219\u201325.","journal-title":"Pain"},{"key":"321_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/15360288.2016.1145780","volume":"30","author":"U Freo","year":"2016","unstructured":"Freo U, Ambrosio F, Furnari M, Ori C. Lidocaine 5% medicated plaster for spinal neuropathic pain. J Pain Palliat Care Pharmacother. 2016;30:111\u20133.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"321_CR21","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1097\/PHM.0000000000000301","volume":"94","author":"M Trbovich","year":"2015","unstructured":"Trbovich M, Yang H. Capsaicin 8% patch for central and peripheral neuropathic pain of persons with incomplete spinal cord injury. Am J Phys Med Rehabil. 2015;94:e66\u201372.","journal-title":"Am J Phys Med Rehabil"},{"key":"321_CR22","first-page":"517","volume":"20","author":"J Rabi","year":"2016","unstructured":"Rabi J, Minori J, Abad H, Lee R. Spinal cord injury patients: an open label. Trial. 2016;20:517\u201320.","journal-title":"Trial"},{"key":"321_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807\u201319.","journal-title":"Lancet Neurol"},{"key":"321_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuron.2006.09.021","volume":"52","author":"JN Campbell","year":"2006","unstructured":"Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron. 2006;52:77\u201392.","journal-title":"Neuron"},{"key":"321_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/j.pain.0000000000001213","volume":"159","author":"S Haroutounian","year":"2018","unstructured":"Haroutounian S, Ford AL, Frey K, Nikolajsen L, Finnerup NB, Neiner A, et al. How central is central poststroke pain? The role of afferent input in poststroke neuropathic pain: a prospective, open-label pilot study. Pain. 2018;159:1317\u201324.","journal-title":"Pain"},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/SPC.0000000000000045","volume":"8","author":"M Reimer","year":"2014","unstructured":"Reimer M, Helfert SM, Baron R. Phenotyping neuropathic pain patients: implications for individual therapy and clinical trials. Curr Opin Support Palliat Care. 2014;8:124\u20139.","journal-title":"Curr Opin Support Palliat Care"},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1097\/j.pain.0000000000001190","volume":"159","author":"J Vollert","year":"2018","unstructured":"Vollert J, Magerl W, Baron R, Binder A, Enax-Krumova EK, Geisslingere G, et al. Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models. Pain. 2018;159:1090\u2013102.","journal-title":"Pain"},{"key":"321_CR28","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/ACO.0000000000000642","volume":"31","author":"J Forstenpointner","year":"2018","unstructured":"Forstenpointner J, Rehm S, Gierthm\u00fchlen J, Baron R. Stratification of neuropathic pain patients: the road to mechanism-based therapy? Curr Opin Anaesthesiol. 2018;31:562\u20138.","journal-title":"Curr Opin Anaesthesiol"},{"key":"321_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/M15-0623","volume":"163","author":"RR Bannuru","year":"2015","unstructured":"Bannuru RR, McAlindon TE, Sullivan MC, Wong JB, Kent DM, Schmid CH. Effectiveness and implications of alternative placebo treatments. Ann Intern Med. 2015;163:365.","journal-title":"Ann Intern Med"},{"key":"321_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jpain.2014.12.008","volume":"16","author":"SM Schafer","year":"2015","unstructured":"Schafer SM, Colloca L, Wager TD. Conditioned placebo analgesia persists when subjects know they are receiving a placebo. J Pain. 2015;16:412\u201320.","journal-title":"J Pain"},{"key":"321_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2147\/JPR.S155979","volume":"11","author":"CR Jutzeler","year":"2018","unstructured":"Jutzeler CR, Warner FM, Cragg JJ, Haefeli J, Richards JS, Andresen SR, et al. Placebo response in neuropathic pain after spinal cord injury: a meta-analysis of individual participant data. J Pain Res. 2018;11:901\u201312.","journal-title":"J Pain Res"},{"key":"321_CR32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jpainsymman.2016.09.015","volume":"53","author":"C Sommer","year":"2017","unstructured":"Sommer C, Cruccu G. Topical treatment of peripheral neuropathic pain: applying the evidence. J Pain Symptom Manag. 2017;53:614\u201329.","journal-title":"J Pain Symptom Manag"},{"key":"321_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2147\/JPR.S180792","volume":"12","author":"JM Keppel Hesselink","year":"2019","unstructured":"Keppel Hesselink JM, Kopsky DJ, Bhaskar AK. Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings. J Pain Res. 2019;12:345\u201352.","journal-title":"J Pain Res"},{"key":"321_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2147\/JPR.S243434","volume":"13","author":"DJ Kopsky","year":"2020","unstructured":"Kopsky DJ, Vrancken AFJE, Keppel Hesselink JM, van Eijk RPA, Notermans NC. Usefulness of a double-blind placebo-controlled response test to demonstrate rapid onset analgesia with phenytoin 10% cream in polyneuropathy. J Pain Res. 2020;13:877\u201382.","journal-title":"J Pain Res"}],"container-title":["Spinal Cord Series and Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41394-020-00321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-020-00321-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-020-00321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:41:19Z","timestamp":1670247679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41394-020-00321-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1038\/s41394-020-00321-1","relation":{},"ISSN":["2058-6124"],"issn-type":[{"value":"2058-6124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"15 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DJK is holder of two patent applications: Topical phenytoin for use in the treatment of peripheral neuropathic pain (WO2018106107); and Topical pharmaceutical composition containing phenytoin and a (co-)analgesic for the treatment of chronic pain (WO2018106108).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"73"}}